关键信息
-
基因名
LRG1
- 应用
-
别名
Leucine-rich alpha-2-glycoprotein; LRG; LRG1
-
种属
Mouse
-
表达系统
HEK293
-
标签
C-8*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q91XL1
-
表达区间
L33-L342
-
氨基酸序列
LKECLILQSAEGSTVSCHGPTEFPSSLPADTVHLSVEFSNLTQLPAAALQGCPGLRELHLSSNRLQALSPELLAPVPRLRALDLTRNALRSLPPGLFSTSANLSTLVLRENQLREVSAQWLQGLDALGHLDLAENQLSSLPSGLLASLGALHTLDLGYNLLESLPEGLLRGPRRLQRLHLEGNRLQRLEDSLLAPQPFLRVLFLNDNQLVGVATGSFQGLQHLDMLDLSNNSLSSTPPGLWAFLGRPTRDMQDGFDISHNPWICDKNLADLCRWLVANRNKMFSQNDTRCAGPEAMKGQRLLDVAELGSL
-
蛋白长度
Full Length of Mature Protein
-
分子量
40-60 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
LRG1 (Leucine-rich alpha-2-glycoprotein 1) is a glycoprotein that has gained significant attention in recent years due to its potential role in various biological processes and diseases. Initially identified as a protein associated with acute phase responses, LRG1 has been implicated in inflammatory conditions, cancer, and cardiovascular diseases. Its expression levels have been shown to correlate with disease severity, making it a candidate for diagnostic and prognostic biomarkers. Research indicates that LRG1 may play a role in angiogenesis, tissue repair, and the modulation of immune responses. As a result, the recombinant production of LRG1 has become a focal point for scientists seeking to further understand its functional roles and underlying mechanisms. By expressing LRG1 in suitable systems, researchers can study its biochemical properties, elucidate its interactions with other proteins, and investigate its impact on cellular pathways. Such studies are vital for determining LRG1's therapeutic potential and paving the way for new treatment strategies targeting its associated pathways. Understanding the properties and functions of LRG1 through recombinant technology may ultimately contribute to advancements in precision medicine and the development of novel diagnostic tools.
